Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Phyllis Lensker
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen,
Comprehensive Cancer Center Erlangen
Observed institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen,
Comprehensive Cancer Center Erlangen
ORCID:
0009-0005-8024-2839
Observed ORCID:
0009-0005-8024-2839
OpenAlex ID:
A5115012359
Therapeutic drug monitoring of imatinib in paediatric chronic myeloid leukaemia: Data from a real‐world setting
2025
·
Meinolf Suttorp
, Stephanie Sembill
, et al.
·
British Journal of Haematology
·
5
Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data
2025
·
Michael I. Sponfeldner
, Pauline Dürr
, et al.
·
Clinical Pharmacology & Therapeutics
·
4
PDF
Medication safety with oral antitumour therapeutics in paediatrics (youngAMBORA): A mixed-methods approach towards a tailored care program
2024
·
Phyllis Lensker
, Lisa Cuba
, et al.
·
PLoS ONE
·
4
Patient‐reported outcomes and medication errors during oral antitumour therapy in paediatrics: Results from the youngAMBORA care programme
2026
·
Phyllis Lensker
, Lisa Cuba
, et al.
·
British Journal of Clinical Pharmacology
PDF
Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma Concentrations
2026
·
Phyllis Lensker
, Andrea Gottschalk
, et al.
·
Clinical Pharmacokinetics
Show more works
View as search
Works count:
5
Citation count:
13
H-index:
3
I10-index:
Year
Topic
Type